Frontiers | Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy
Induction Therapy in Renal Transplantation | Semantic Scholar
Single-Dose Basiliximab Induction Therapy in Low-Immunologic Risk Kidney Transplant Recipients - ATC Abstracts
Novel approaches to improve recipient and allograft outcomes | Nature Reviews Nephrology
The induction and initial maintenance immunosuppression regimens. | Download Scientific Diagram
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials - The Lancet
Immunosuppressive Drugs for Kidney Transplantation | NEJM
Induction treatment in Kidney transplantation chaken 2017 | PPT
The impact of universal induction therapy on early hospital readmission of kidney transplant recipients - Brazilian Journal of Nephrology (BJN)
Where do we stand in 2020 regarding induction therapy after kidney transplantation? - Rostaing - 2020 - Transplant International - Wiley Online Library
The Changing Tides of Immunosuppression - Renal Fellow Network
SciELO - Brasil - Diferentes esquemas de indução para transplante renal com doador vivo Diferentes esquemas de indução para transplante renal com doador vivo
JCM | Free Full-Text | Preventing Rejection of the Kidney Transplant
Immunosuppression induction regimens and maintenance target blood levels. | Download Scientific Diagram
Overview of Immunosuppression in Renal Transplantation | IntechOpen
Toxins | Free Full-Text | Monoclonal Antibody Therapy and Renal Transplantation: Focus on Adverse Effects
Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study | BMC Nephrology | Full Text
Rabbit Antithymocyte Globulin versus Basiliximab in Renal Transplantation | NEJM
![Thymoglobulin® Efficacy & Safety | Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)]](https://www.thymoglobulin.com/Images/mobile/trial_design_m.png "Thymoglobulin® Efficacy & Safety | Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)]")
Thymoglobulin® Efficacy & Safety | Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)]
Induction therapy for living-donor transplant recipients in use at HC... | Download Scientific Diagram
Frontiers | Regulatory B Cell Therapy in Kidney Transplantation
JCM | Free Full-Text | Outcome Comparison between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation
Overview of early immunosuppression options after kidney... | Download Table
Impact of Induction Therapy on Circulating T Follicular Helper Cells and Subsequent Donor-Specific Antibody Formation After Kidney Transplant - ScienceDirect
Standard induction with basiliximab versus no induction in low immunological risk kidney transplant recipients: study protocol for a randomized controlled trial | Trials | Full Text
Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients | BMC Nephrology | Full Text
